Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
Crossref DOI link: https://doi.org/10.1186/s12935-024-03508-w
Published Online: 2024-09-18
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Xuejiao
Tu, Yiming
Wang, Yifeng
Zhou, Di
Chong, Yulong
Shi, Lin
Liu, Guanzheng
Zhang, Xu
Wu, Sijin
Li, Huan
Gao, Shangfeng
Niu, Mingshan
Yu, Rutong
Text and Data Mining valid from 2024-09-18
Version of Record valid from 2024-09-18
Article History
Accepted: 13 September 2024
First Online: 18 September 2024